An inquiry into the ImClone cancer-drug story

hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

0 (0 Ratings)

0 Want to read0 Currently reading0 Have read

Publish Date

2002

Publisher

U.S. G.P.O.,For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office]

Language

eng

Pages

759

Description:

subjects: Cetuximab, Corrupt practices, Drugs, ImClone Systems Incorporated, Insider trading in securities, Testing, Drugs, testing, Business enterprises, corrupt practices

Places: United States